Tops & Flops Stocks
Security ▼ | Change (%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Takeda Pharmaceutical Co Ltd | 1.310% | 1.372% | 3.289% | -9.608% | -3.198% | -12.656% | -16.821% |
Takara Bio Inc. | -2.260% | 2.308% | 13.675% | -40.090% | -13.636% | -69.213% | -61.161% |
Tactile Systems Technology Inc | - | 2.655% | 12.621% | -41.117% | -10.078% | -71.000% | - |
Tabula Rasa HealthCare Inc | -1.520% | - | - | - | - | - | - |
T2 Biosystems Inc. | -44.060% | - | - | - | - | - | - |
Sysmex Corp. | 0.710% | -2.083% | -8.442% | -76.303% | -71.107% | -86.040% | -76.870% |
Syros Pharmaceuticals Inc. | -1.870% | 0.901% | 3.704% | 75.549% | -15.152% | -86.854% | - |
Synthetic Biologics Inc. | -1.510% | 0.000% | 15.124% | -56.410% | -36.250% | -94.383% | -94.242% |
Synergy Pharmaceuticals | - | - | - | - | - | - | - |
Syndax Pharmaceuticals Inc | 3.670% | 6.542% | 25.275% | 16.327% | 21.925% | 65.217% | - |
Synairgen plc | - | 53.731% | -17.600% | -36.183% | -20.647% | -97.095% | -51.869% |
Swedish Orphan Biovitrum Ab | -1.020% | 5.399% | 1.439% | 43.309% | 5.137% | 51.161% | 28.604% |
Sutro Biopharma Inc | -1.680% | -2.186% | 26.950% | -10.050% | -7.732% | -75.811% | - |
Sustainable Nutrition Group Ltd. | - | - | - | - | - | - | - |
Surgery Partners Inc | 3.680% | 2.256% | 28.302% | -23.164% | -5.556% | -43.096% | 332.639% |
Surgalign Holdings Inc. | -39.530% | - | - | - | - | - | - |
Super Sonic Imagine | 0.680% | - | - | - | - | - | - |
Supernus Pharmaceuticals | 1.440% | 4.511% | 11.200% | 1.460% | 6.107% | 19.828% | -2.797% |
Super League Gaming Inc | -6.540% | - | - | - | - | - | - |
Summit Therapeutics plc | -33.450% | - | - | - | - | - | - |
Stryker Corp. | 0.990% | -0.691% | -4.702% | 14.742% | 11.935% | 35.365% | 56.672% |
Strongbridge Biopharma plc | 0.590% | - | - | - | - | - | - |
Stratec SE | -0.480% | -1.308% | -10.076% | -18.627% | -9.586% | -67.220% | -28.571% |
Strata Skin Sciences Inc. | 24.500% | - | - | - | - | - | - |
Stoke Therapeutics Inc | 3.790% | 7.200% | 0.752% | - | - | - | - |